Profil
Christopher Williams is currently the Head of Media Relations at Juno Therapeutics, Inc. and the Chief Communications Officer at Compass Pathways Plc.
He previously worked as the Vice President and Head of Corporate Communications at Sanofi SA.
Postes actifs de Christopher Williams
| Sociétés | Poste | Début |
|---|---|---|
| COMPASS PATHWAYS PLC | Public Communications Contact | - |
Anciens postes connus de Christopher Williams
| Sociétés | Poste | Fin |
|---|---|---|
| JUNO THERAPEUTICS INC | Public Communications Contact | 01/02/2018 |
| Sanofi SA | Public Communications Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COMPASS PATHWAYS PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Sanofi SA | Health Technology |